Papers
2
Total Citations
9
H-Index
2
About
Haichang Li is a pioneering urologic surgeon whose research is reshaping the landscape of minimally invasive kidney and prostate cancer surgery. His work centers on two critical frontiers: advancing robotic surgical systems and perfecting nephron-sparing techniques. Li has conducted head-to-head comparisons of the da Vinci and Toumai® robotic platforms for radical prostatectomy and partial nephrectomy, providing vital data on the efficacy of emerging domestic robotic systems. His most impactful contribution is the development of a zero-ischaemia approach to robotic-assisted laparoscopic partial nephrectomy (RALPN), achieved through preoperative superselective transarterial embolization. In a landmark study of 32 T1 renal cancer patients, Li demonstrated that this technique can eliminate warm ischaemia time—a major cause of postoperative renal function loss—without compromising oncologic outcomes. His work has garnered over 9 citations in just two years, reflecting its immediate relevance to practicing surgeons. By systematically evaluating both established and novel robotic platforms while pioneering bloodless partial nephrectomy, Li is helping to define the next generation of precision, kidney-sparing cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2